TY - JOUR
T1 - 4D Bioprinting Shape-Morphing Tissues in Granular Support Hydrogels
T2 - Sculpting Structure and Guiding Maturation
AU - Pramanick, Ankita
AU - Hayes, Thomas
AU - Sergis, Vasileios
AU - McEvoy, Eoin
AU - Pandit, Abhay
AU - Daly, Andrew C.
N1 - Publisher Copyright:
© 2024 The Author(s). Advanced Functional Materials published by Wiley-VCH GmbH.
PY - 2025/1/29
Y1 - 2025/1/29
N2 - During embryogenesis, organs undergo dynamic shape transformations that sculpt their final shape, composition, and function. Despite this, current organ bioprinting approaches typically employ bioinks that restrict cell-generated morphogenetic behaviors resulting in structurally static tissues. This work introduces a novel platform that enables the bioprinting of tissues that undergo programmable and predictable 4D shape-morphing driven by cell-generated forces. This method utilizes embedded bioprinting to deposit collagen-hyaluronic acid bioinks within yield-stress granular support hydrogels that can accommodate and regulate 4D shape-morphing through their viscoelastic properties. Importantly, precise control over 4D shape-morphing is possible by modulating factors such as the initial print geometry, cell phenotype, bioink composition, and support hydrogel viscoelasticity. Further, shape-morphing is found to actively sculpt cell and extracellular matrix alignment along the principal tissue axis through a stress-avoidance mechanism. To enable predictive design of 4D shape-morphing patterns, a finite element model is developed that accurately captures shape evolution at both the cellular and tissue levels. Finally, it is demonstrated that programmed 4D shape-morphing enhances the structural and functional properties of iPSC-derived heart tissues. This ability to design, predict, and program 4D shape-morphing holds great potential for engineering organ rudiments that recapitulate morphogenetic processes to sculpt their final shape, composition, and function.
AB - During embryogenesis, organs undergo dynamic shape transformations that sculpt their final shape, composition, and function. Despite this, current organ bioprinting approaches typically employ bioinks that restrict cell-generated morphogenetic behaviors resulting in structurally static tissues. This work introduces a novel platform that enables the bioprinting of tissues that undergo programmable and predictable 4D shape-morphing driven by cell-generated forces. This method utilizes embedded bioprinting to deposit collagen-hyaluronic acid bioinks within yield-stress granular support hydrogels that can accommodate and regulate 4D shape-morphing through their viscoelastic properties. Importantly, precise control over 4D shape-morphing is possible by modulating factors such as the initial print geometry, cell phenotype, bioink composition, and support hydrogel viscoelasticity. Further, shape-morphing is found to actively sculpt cell and extracellular matrix alignment along the principal tissue axis through a stress-avoidance mechanism. To enable predictive design of 4D shape-morphing patterns, a finite element model is developed that accurately captures shape evolution at both the cellular and tissue levels. Finally, it is demonstrated that programmed 4D shape-morphing enhances the structural and functional properties of iPSC-derived heart tissues. This ability to design, predict, and program 4D shape-morphing holds great potential for engineering organ rudiments that recapitulate morphogenetic processes to sculpt their final shape, composition, and function.
KW - 4D shape-morphing
KW - embedded bioprinting
KW - granular hydrogels
KW - heart tissue
KW - iPSC-derived cardiomyocytes
UR - http://www.scopus.com/inward/record.url?scp=85210027664&partnerID=8YFLogxK
U2 - 10.1002/adfm.202414559
DO - 10.1002/adfm.202414559
M3 - Article
SN - 1616-301X
VL - 35
JO - Advanced Functional Materials
JF - Advanced Functional Materials
IS - 5
M1 - 2414559
ER -